Three ways Silicon Valley is trying to beat DEATH after Jeff Bezos immortality plot revealed

IMMORTALITY might soon be a reality in Silicon Valley — here are three ways the community is trying to cheat death.

Silicon Valley titans, including the world’s second-richest man Jeff Bezos, are spending enormous amounts of money on anti-aging technology and strange treatments that might someday allow humans to live forever.

Jeff Bezos invested in Alto Labs, whose core mission is to rejuvenate cells for anti-aging

Silicon Valley seems to be the world capital for the eternal youth quest because the people there have both the money and technological means to try to tackle a project like this.

Some experts from the community have even speculated that humans could achieve immortality by 2050 by using what they believe to be life-extending treatments, including injecting plasma and infusing humans with A.I. body parts.

Here are three ‘anti-aging’ methods currently in the works.

Cellular rejuvenation

Jeff Bezos has invested in a new anti-aging startup designated Alto Labs, which launched formally on Wednesday.

The new biotechnology company is dedicated to defeating death by unraveling the biology of cellular rejuvenation programming.

This is a method of essentially rejuvenating cells after they’ve matured to theoretically enable them to repair your body as it ages or to tackle age-related diseases like dementia. 

Some of the members on the team include CEO Hal Barron, formerly the chief scientific officer at the pharmaceutical giant GlaxoSmithKline, and two Nobel Laureates: Dr. Shinya Yamanaka and Jennifer Doudna.

Young blood transfusion

The concept of transfusing older people with a younger person’s blood might sound incredibly bizarre, but according to Stanford-trained scientist Jesse Karmazin, it has merit.

Karmazin in 2016 founded Ambrosia, whic used blood plasma as a tool to help conquer aging.

The idea behind this method was to fill the veins of older people with plasma from younger donors’ blood in the hopes that the procedure would rejuvenate the body’s organ.

More than 100 people took part in the initial clinical trial, and the results, according to Karmazin, were promising.

“It could help improve things such as appearance or diabetes or heart function or memory. These are all the aspects of aging that have a common cause,” Karmazin said.

“I’m not really in the camp of saying this will provide immortality but I think it comes pretty close, essentially,” he added.

After facing a hiccup with the US Food and Drug Administration (FDA) in 2019, the company resumed services in all 50 states in 2020, according to Karmazin.

Each transfusion procedure costs around $8,000.

A.I. body parts

Many scientists around the world are working on creating human organs in labs or by using 3D printers loaded with living cells, which could one day make human organ donors obsolete.

Some experts, however, are approaching this method in another way: Robotic A.I. body parts.

One doesn’t have to look further than Elon Musk’s Neuralink to see that is already well underway.

As recently as this week, the company began recruiting a clinical trial director to begin trials for implanting brain chips in humans.

The chips, according to Musk, could help humans overcome diseases and even paralysis.

Furthermore, the billionaire believes the technology could eventually allow humans to develop a copy of themselves — which will live even after their body dies.

He told CNBC: “If your biological self dies, you can upload into a new unit. Literally.”

AlamyOne company is using blood transfusions to tackle anti-aging.[/caption]

In other news, personalised smart guns, which can be fired only by verified users, may finally become available to U.S. consumers this year.

Tech giant Microsoft is trying to make the world more woke by rolling out an “inclusiveness” checker in its Word software.

And a federal anti-trust case against Meta, the company formerly known as Facebook, has been given the go-ahead.